Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.1% |
| EBIT Margin |
15.4% |
| EBITDA Margin |
28.6% |
| Operating Margin |
32.7% |
| Pretax Margin |
13.8% |
| Cont. Ops Margin |
11.4% |
| Net Margin |
17.9% |
| Bottom Line Margin |
17.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.09 |
| Quick Ratio |
1.09 |
| Solvency Ratio |
0.246 |
| Cash Ratio |
0.26 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.30 |
| Forward PEG |
0.30 |
| Price/Book |
1.42 |
| Price/Sales |
2.32 |
| Price/FCF |
11.25 |
| Price/Op Cash Flow |
9.40 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1604 |
| Debt/Equity |
0.2849 |
| Debt/Capital |
0.2217 |
| Long-Term Debt/Capital |
0.1665 |
| Financial Leverage |
1.78 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
5.44 |
| Operating Cash Flow Ratio |
0.379 |
| Operating Cash Flow/Sales |
24.6% |
| Free Cash Flow/Operating Cash Flow |
83.6% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.33 |
| Interest Coverage |
25.3126 |
| Short-Term Operating Cash Flow Coverage |
2.47 |
| Operating Cash Flow Coverage |
0.53 |
| Capital Expenditure Coverage |
6.10 |
| Dividend + Capital Expenditure Coverage |
1.65 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
61.0777% |
| Dividend Yield |
4.7200% |
| Dividend Yield % |
4.7200% |
| Dividend Per Share |
3.9087 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
35.73 |
| EPS |
6.400 |
| Debt/Share |
17.1188 |
| Cash/Share |
6.29 |
| Book Value/Share |
58.74 |
| Tangible BV/Share |
3.40 |
| Equity/Share |
58.46 |
| Operating Cash Flow/Share |
8.805 |
| Capital Expenditure/Share |
1.443 |
| FCF/Share |
7.362 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.298 |
| Earnings Before Tax/EBIT |
0.422 |
| Price/Fair Value |
1.42 |
| Debt/Market Cap |
0.1839 |
| Effective Tax Rate |
17.3% |
| Enterprise Value Multiple |
9.15 |
SNYNF - Sanofi